Investor Presentaiton

Global market opportunity: USD $31.3 billion p.a. global spend • The market segmentation by the number of procedures. 4DMedical™ Market Opportunity by Country² Country Spend (USD) Procedures US 13,716M 73.5M X-ray Technology (67.05%) Others 4,964M 59.8M Procedures Expenditure 253m Germany 2,678M 20.3M USD $14.5 billion Japan 1,905M 22.8M China 1,851M 101.6M UK 1,351M 8.9M Pulmonary Function Tests (20.9%) France 1,191M 10.2M Spain 780M 8.4M Nuclear Medicine (0.4%) Computed Tomography (CT) (11.8%) Italy 681M 8.5M Canada 606M 8.0M South Korea 450M 6.8M Turkey 346M 16.1M Australia 285M 5.3M India 276M 25.3M Procedures Expenditure 78.9m Procedures 1.44m Procedures 44.5m USD $3.4 billion Expenditure USD $1.6 billion Expenditure USD $11.9 billion Switzerland 197M 1.2M Israel 69M 1.1M These four technologies account for the 3782 million respiratory diagnostics tests performed annually. 4DMedical Limited | Investor Presentation | November 2022 1. Frost and Sullivan Report 2020 2. Frost and Sullivan Report 2020 5

View entire presentation